Skip to main content
Premium Trial:

Request an Annual Quote

Denator Raises $3.6M in Sixth Funding Round


Swedish biotech firm Denator said this week it has completed its sixth financing round, securing €2.75 million ($3.66 million) in funding.

According to a statement by Denator CEO Olof Skold, the funds will be used to continue market expansion and development of the firm's heat-stabilization technology, which uses rapid heating as opposed to conventional snap-freezing to halt enzyme activity in biological samples, thus preserving them for analysis.

Effective sample collection and preservation has emerged as a key challenge in proteomics, particularly with regard to analyses of protein phosphorylation, which is a highly labile post-translational modification.

Although phosphorylation is a prime area of interest within proteomics — particularly in the pharmaceutical and clinical arenas where researchers are studying phosphoproteins in hopes of developing and better targeting kinase inhibitors for the treatment of a variety of diseases — the lack of a good method for preserving tissue samples intended for phosphoproteomic research has been a significant impediment to this work.

Existing investors and new investors Novo Seeds – the early stage investment group of Novo A/S – and venture capital firm Almi Invest participated in the funding round.

In conjunction with the financing, Soren Moller, managing investment director at Novo Seeds, joined Denator's board of directors.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.